
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9831941
[patent_doc_number] => 08940756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 13/801753
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73804
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801753
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801753 | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | Mar 12, 2013 | Issued |
Array
(
[id] => 9198840
[patent_doc_number] => 20130338156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'IMIDAZOPYRIDIN-2-ONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/800907
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102744
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13800907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/800907 | Imidazopyridin-2-one derivatives | Mar 12, 2013 | Issued |
Array
(
[id] => 9081965
[patent_doc_number] => 20130267495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/800963
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35478
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13800963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/800963 | Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof | Mar 12, 2013 | Issued |
Array
(
[id] => 9626625
[patent_doc_number] => 08796305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use'
[patent_app_type] => utility
[patent_app_number] => 13/789414
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22508
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789414
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789414 | Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use | Mar 6, 2013 | Issued |
Array
(
[id] => 8928554
[patent_doc_number] => 20130184313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/789085
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 132796
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789085 | NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF | Mar 6, 2013 | Abandoned |
Array
(
[id] => 9589423
[patent_doc_number] => 08778964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use'
[patent_app_type] => utility
[patent_app_number] => 13/789208
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56899
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13789208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/789208 | Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use | Mar 6, 2013 | Issued |
Array
(
[id] => 9042358
[patent_doc_number] => 20130244996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'BENZODIOXANE INHIBITORS OF LEUKOTRIENE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 13/785034
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43793
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13785034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/785034 | Benzodioxane inhibitors of leukotriene production | Mar 4, 2013 | Issued |
Array
(
[id] => 9496774
[patent_doc_number] => 08735593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Aminopyridines useful as inhibitors of protein kinases'
[patent_app_type] => utility
[patent_app_number] => 13/785019
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14123
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13785019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/785019 | Aminopyridines useful as inhibitors of protein kinases | Mar 4, 2013 | Issued |
Array
(
[id] => 9552323
[patent_doc_number] => 08759372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate salt'
[patent_app_type] => utility
[patent_app_number] => 13/775528
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 14589
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775528
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775528 | N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate salt | Feb 24, 2013 | Issued |
Array
(
[id] => 8892255
[patent_doc_number] => 20130165439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/775601
[patent_app_country] => US
[patent_app_date] => 2013-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10854
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13775601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/775601 | CHEMICAL COMPOUNDS | Feb 24, 2013 | Abandoned |
Array
(
[id] => 9839806
[patent_doc_number] => 20150031887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => '9-AZANORADAMANTANE N-OXYL COMPOUND AND METHOD FOR PRODUCING SAME, AND ORGANIC OXIDATION CATALYST AND METHOD FOR OXIDIZING ALCOHOLS USING 9-AZANORADAMANTANE N-OXYL COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/380794
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13124
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380794
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/380794 | 9-azanoradamantane N—oxyl compound and method for producing same, and organic oxidation catalyst and method for oxidizing alcohols using 9-azanoradamantane N—oxyl compound | Feb 21, 2013 | Issued |
Array
(
[id] => 9865331
[patent_doc_number] => 20150045349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 14/379343
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68957
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14379343
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/379343 | Heterocyclic compound | Feb 18, 2013 | Issued |
Array
(
[id] => 10844770
[patent_doc_number] => 08871948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => '(Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor'
[patent_app_type] => utility
[patent_app_number] => 13/768013
[patent_app_country] => US
[patent_app_date] => 2013-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18162
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13768013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/768013 | (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor | Feb 14, 2013 | Issued |
Array
(
[id] => 10844610
[patent_doc_number] => 08871787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester'
[patent_app_type] => utility
[patent_app_number] => 13/763063
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6677
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763063
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/763063 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester | Feb 7, 2013 | Issued |
Array
(
[id] => 10090189
[patent_doc_number] => 09127002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Process for manufacturing a naphthyridine derivative'
[patent_app_type] => utility
[patent_app_number] => 14/377890
[patent_app_country] => US
[patent_app_date] => 2013-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9179
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377890
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377890 | Process for manufacturing a naphthyridine derivative | Feb 7, 2013 | Issued |
Array
(
[id] => 8905046
[patent_doc_number] => 20130172549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Heteroaryl amide derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/812960
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30779
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/812960 | Heteroaryl amide derivatives | Jan 28, 2013 | Abandoned |
Array
(
[id] => 9995956
[patent_doc_number] => 09040555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-26
[patent_title] => 'Antifibrotic compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/374210
[patent_app_country] => US
[patent_app_date] => 2013-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20524
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14374210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/374210 | Antifibrotic compounds and uses thereof | Jan 25, 2013 | Issued |
Array
(
[id] => 9016400
[patent_doc_number] => 20130231364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR'
[patent_app_type] => utility
[patent_app_number] => 13/750400
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19837
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13750400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/750400 | Modulators of cystic fibrosis transmembrane conductance regulator | Jan 24, 2013 | Issued |
Array
(
[id] => 9122141
[patent_doc_number] => 20130289063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/746688
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746688
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746688 | CCR1 ANTAGONISTS AND METHODS OF USE THEREFOR | Jan 21, 2013 | Abandoned |
Array
(
[id] => 10001416
[patent_doc_number] => 09045493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/377528
[patent_app_country] => US
[patent_app_date] => 2013-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34265
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377528
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/377528 | Furo[3,2-b]- and thieno[3,2-b]pyridin derivatives | Jan 2, 2013 | Issued |